Ruirui Gui

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Extracorporeal Membrane Oxygenation

Stem Cell Transplantation

Peripheral Blood

Top Venues

British journal of haematology

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Yang, Quan Ren, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Baijun Fang, Yuewen Fu, Yongliang Wang, Yanyan Liu, Lina Zhang, Wenli Zuo, Yufu Li, Quande Lin, Huifang Zhao, Ping Wang, Binglei Zhang, Zhenghua Huang, Yong-Ping Song, Jian Zhou
Multiple small-dose infusions of G-CSF-mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia. British journal of haematology (2024)
Fei Yang, Quan Ren, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Baijun Fang, Yuewen Fu, Yongliang Wang, Yanyan Liu, Lina Zhang, Wenli Zuo, Yufu Li, Quande Lin, Huifang Zhao, Ping Wang, Binglei Zhang, Zhenghua Huang, Yong-Ping Song, Jian Zhou
Multiple small-dose infusions of G-CSF-mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia. British journal of haematology 205 (2) (2024)
Wenli Zhang, Ruirui Gui, Yingling Zu, Binglei Zhang, Zhen Li, Yanli Zhang, Xianjing Wang, Shuli Guo, Xinrong Zhan, Yuewen Fu, Yong-Ping Song, Jian Zhou
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial. British journal of haematology (2022)
Yingling Zu, Zhen Li, Ruirui Gui, Yanyan Liu, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Yuewen Fu, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Jian Zhou, Yong-Ping Song
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Bone marrow transplantation 57 (10) (2022)